Renal Disease

• FDA approval · 2011-09-22
  FDA Approved: TORSEMIDE — Supplemental Application (Rising Pharma Holdings, Inc.)

  The FDA issued a supplemental approval for Torsemide from Rising Pharma Holdings, approving a generic torsemide product.

• FDA approval · 2011-01-27
  FDA Approved: FUROSEMIDE — Supplemental Application (Ipca Laboratories Limited)

  FDA approved a supplemental application for furosemide from Ipca Laboratories Limited under an ANDA, signaling approval of changes to the ge…

• FDA approval · 2011-01-26
  FDA Approved: FUROSEMIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

  The FDA approved a supplemental application for furosemide filed by Hikma Pharmaceuticals USA Inc., updating the approved generic product un…

• FDA approval · 2010-09-28
  FDA Approved: TORSEMIDE — Supplemental Application (Chartwell RX, LLC)

  The FDA approved a supplemental application for torsemide submitted by Chartwell RX, LLC under ANDA 076894. The action approves changes to t…

• FDA approval · 2009-05-04
  FDA Approved: FUROSEMIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

  The FDA approved a supplemental application for furosemide submitted by Hikma Pharmaceuticals USA Inc.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2008-10-22
  FDA Approved: LASIX — Supplemental Application (Validus Pharmaceuticals LLC)

  The FDA approved a supplemental application for LASIX (furosemide) from Validus Pharmaceuticals LLC.

• FDA approval · 2008-04-30
  FDA Approved: BUMETANIDE — Original Application (Civica, Inc.)

  FDA approved Civica, Inc.'s original application for bumetanide, authorizing a generic version of the diuretic bumetanide.

• FDA approval · 2007-10-03
  FDA Approved: TORSEMIDE — Supplemental Application (Chartwell RX, LLC)

  FDA approved a supplemental application for Torsemide from Chartwell RX, LLC.

• FDA approval · 2007-08-09
  FDA Approved: FUROSEMIDE — Supplemental Application (Solco Healthcare LLC)

  FDA approved a supplemental application for furosemide submitted by Solco Healthcare LLC.

• FDA approval · 2007-06-29
  FDA Approved: FUROSEMIDE — Supplemental Application (Leading Pharma, LLC)

  FDA approves a supplemental application for furosemide submitted by Leading Pharma, LLC.

• FDA approval · 2007-03-28
  FDA Approved: FUROSEMIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

  FDA approved a supplemental application for furosemide by Hikma Pharmaceuticals USA Inc., approving regulatory action on an existing generic…

• CLINICAL_TRIALS trial_result · 2006-10-09
  Clinical Trial Update: Olmesartan Medoxomil and Diabetic Nephropathy [Phase 3]

  A Phase 3 trial evaluating Olmesartan Medoxomil for diabetic nephropathy in type 2 diabetes has been completed.